stars 1 stars 2 stars 3

Galenvs is a specialized precision developer & manufacturer of nanomaterials and DNA/RNA oligonucleotides for therapeutics and diagnostic applications, offering services from proof-of-concept through in-vitro validation and pilot-scale production. Why choose us? - Proven track record of delivering solutions for a variety of industries from human to environmental and animal health - Vertical integration from lead optimization, synthesis, purification, validation and pilot-scale production - Rapid turnaround from proof-of-concept to pilot-scale informed by rich data set and predictive models Our proprietary multidisciplinary technologies in functional nanomaterials and oligonucleotide synthesis deliver value for our healthcare and industry partners. We excel in tackling complex challenges and designing robust, tailored processes optimized for client product requirements.

Galenvs Sciences Questions

The Galenvs Sciences annual revenue was $200000 in 2026.

David Lapointe is the President and General Manager of Galenvs Sciences.

10 people are employed at Galenvs Sciences.

Galenvs Sciences is based in Montreal, Quebec.

The NAICS codes for Galenvs Sciences are [54171, 541, 5417, 541714, 54].

The SIC codes for Galenvs Sciences are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users